News
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 24.39 crore in the September 2026 quarter
03-Nov-2026 | 07:47
Sales rise 282.06% to Rs 30.03 crore
Net Loss of Sun Pharma Advanced Research Company reported to Rs 24.39 crore in the quarter ended September 2026 as against net loss of Rs 75.85 crore during the previous quarter ended September 2025. Sales rose 282.06% to Rs 30.03 crore in the quarter ended September 2026 as against Rs 7.86 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 30.03 | 7.86 | 282 |
| OPM % | -151.88 | -836.13 | - |
| PBDT | -22.11 | -73.23 | 70 |
| PBT | -24.31 | -75.79 | 68 |
| NP | -24.39 | -75.85 | 68 |
Powered by Capital Market - Live News